197 related articles for article (PubMed ID: 15203884)
1. Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin-induced diabetic rats.
Ramachandran B; Sekar DS; Kandaswamy M; Narayanan V; Subramanian S
Exp Diabesity Res; 2004; 5(2):137-42. PubMed ID: 15203884
[TBL] [Abstract][Full Text] [Related]
2. Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats.
Ramachandran B; Kandaswamy M; Narayanan V; Subramanian S
Diabetes Obes Metab; 2003 Nov; 5(6):455-61. PubMed ID: 14617232
[TBL] [Abstract][Full Text] [Related]
3. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
4. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
6. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
Shinde UA; Mehta AA; Goyal RK
Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
[TBL] [Abstract][Full Text] [Related]
8. Effective control of blood glucose status and toxicity in streptozotocin-induced diabetic rats by orally administration of vanadate in an herbal decoction.
Zhang L; Zhang Y; Xia Q; Zhao XM; Cai HX; Li DW; Yang XD; Wang K; Xia ZL
Food Chem Toxicol; 2008 Sep; 46(9):2996-3002. PubMed ID: 18601969
[TBL] [Abstract][Full Text] [Related]
9. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Dabroś W; Kajda B
Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
[TBL] [Abstract][Full Text] [Related]
10. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
11. Anti-diabetic effects of cesium aqua (N,N'-ethylene(salicylideneiminato)-5-sulfonato) oxovanadium (IV) dihydrate in streptozotocin-induced diabetic rats.
Li M; Wei D; Ding W; Baruah B; Crans DC
Biol Trace Elem Res; 2008 Mar; 121(3):226-32. PubMed ID: 17968514
[TBL] [Abstract][Full Text] [Related]
12. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
13. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
Xie M; Gao L; Li L; Liu W; Yan S
J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats.
Nandhini D; Maneemegalai S; Elangovan V; Sekar N; Govindasamy S
Indian J Biochem Biophys; 1993 Feb; 30(1):73-6. PubMed ID: 8509129
[TBL] [Abstract][Full Text] [Related]
15. Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R; Giridhar R; Yadav MR
J Trace Elem Med Biol; 2005; 18(3):211-7. PubMed ID: 15966569
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization and antidiabetic properties of N(1)-2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV).
Yanardag R; Demirci TB; Ulküseven B; Bolkent S; Tunali S; Bolkent S
Eur J Med Chem; 2009 Feb; 44(2):818-26. PubMed ID: 18621448
[TBL] [Abstract][Full Text] [Related]
17. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
[TBL] [Abstract][Full Text] [Related]
18. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
[TBL] [Abstract][Full Text] [Related]
20. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
